Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Revenue 2020–2025
Enanta Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Enanta Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 17.2 M.
- Enanta Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 69.2 M.
- Enanta Pharmaceuticals Inc. annual revenue for 2025 was 65.3 M, a 3.42% decrease from 2024.
- Enanta Pharmaceuticals Inc. annual revenue for 2024 was 67.6 M, a 14.61% decrease from 2023.
- Enanta Pharmaceuticals Inc. annual revenue for 2023 was 79.2 M, a 8.07% decrease from 2022.
- Enanta Pharmaceuticals Inc. annual revenue for 2022 was 86.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Enanta Pharmaceuticals Inc. Earnings — FAQ
Enanta Pharmaceuticals Inc. (ENTA) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's earnings history?
The chart and table above show Enanta Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.